• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一类新型的内皮素 A 受体拮抗剂,(R)-2-(苯并[1,3]二氧杂环戊烯-5-基)-6-异丙氧基-2H-色烯-3-羧酸(S-1255)。对 ET(A)拮抗作用至关重要的基本结构在溶液和固态下的构象分析。

A novel class of endothelin-A receptor antagonists, (R)-2-(benzo[1,3]dioxol-5-yl)-6-isopropyloxy-2H-chromene-3-carboxylic acids (S-1255). Conformational analysis of basic structure, crucial for ET(A) antagonism, in solution and solid states.

作者信息

Ishizuka Natsuki, Matsumura Ken-ichi, Kikuchi Junko, Nakai Hiroshi

机构信息

Shionogi Research Laboratories, Shionogi & Co., Ltd., 12-4, Sagisu 5-chome, Fukushima-ku, Osaka, Japan.

出版信息

Bioorg Med Chem. 2002 Dec;10(12):3965-72. doi: 10.1016/s0968-0896(02)00300-0.

DOI:10.1016/s0968-0896(02)00300-0
PMID:12413848
Abstract

Conformational studies of potent and selective endothelin-A (ET(A)) receptor antagonists, 4-substituted (R)-2-(benzo[1,3]-dioxol-5-yl)-6-isopropoxy-2H-chromene-3-carboxylic acids, are reported. X-ray crystallography and NMR studies of the 4-anisyl derivative 2 (S-1255), the stable atropisomers 3 and the 4-n-butyl derivative 4 reveal that the A-, B- and C-rings in these compounds adopt a L-like conformation in both solution and solid states. Molecular mechanics calculation shows that this L-like conformation is an inevitable conformation as determined by intramolecular steric repulsions. These 2H-chromene derivatives bound to an ET(A) receptor with IC(50) values of less than 1 nM, whereas the dihydro compounds 7 and 9 not having the L-like conformation showed weaker affinities. These results suggest that the L-like conformation is specifically recognized by the active site of the ET(A) receptor. The roles of the L-like conformation in the receptor binding are discussed.

摘要

报道了强效和选择性内皮素-A(ET(A))受体拮抗剂4-取代的(R)-2-(苯并[1,3]二氧杂环戊烯-5-基)-6-异丙氧基-2H-色烯-3-羧酸的构象研究。对4-茴香基衍生物2(S-1255)、稳定的阻转异构体3和4-正丁基衍生物4进行的X射线晶体学和核磁共振研究表明,这些化合物中的A、B和C环在溶液和固态中均呈现L型构象。分子力学计算表明,这种L型构象是由分子内空间排斥作用决定的必然构象。这些2H-色烯衍生物与ET(A)受体结合,IC(50)值小于1 nM,而不具有L型构象的二氢化合物7和9表现出较弱的亲和力。这些结果表明,L型构象被ET(A)受体的活性位点特异性识别。讨论了L型构象在受体结合中的作用。

相似文献

1
A novel class of endothelin-A receptor antagonists, (R)-2-(benzo[1,3]dioxol-5-yl)-6-isopropyloxy-2H-chromene-3-carboxylic acids (S-1255). Conformational analysis of basic structure, crucial for ET(A) antagonism, in solution and solid states.一类新型的内皮素 A 受体拮抗剂,(R)-2-(苯并[1,3]二氧杂环戊烯-5-基)-6-异丙氧基-2H-色烯-3-羧酸(S-1255)。对 ET(A)拮抗作用至关重要的基本结构在溶液和固态下的构象分析。
Bioorg Med Chem. 2002 Dec;10(12):3965-72. doi: 10.1016/s0968-0896(02)00300-0.
2
Structure-activity relationships of a novel class of endothelin-A receptor antagonists and discovery of potent and selective receptor antagonist, 2-(benzo[1,3]dioxol-5-yl)-6-isopropyloxy-4-(4-methoxyphenyl)-2H-chromene-3-carboxylic acid (S-1255). 1. Study on structure-activity relationships and basic structure crucial for ET(A) antagonism.一类新型内皮素-A受体拮抗剂的构效关系及强效选择性受体拮抗剂2-(苯并[1,3]二氧杂环戊烯-5-基)-6-异丙氧基-4-(4-甲氧基苯基)-2H-色烯-3-羧酸(S-1255)的发现。1. 内皮素-A拮抗作用的构效关系及关键基本结构研究。
J Med Chem. 2002 May 9;45(10):2041-55. doi: 10.1021/jm010382z.
3
Pharmacologic characterization of S-1255, a highly potent and orally active endothelin A receptor antagonist.强效口服活性内皮素A受体拮抗剂S-1255的药理学特性
J Cardiovasc Pharmacol. 2001 Apr;37(4):471-82. doi: 10.1097/00005344-200104000-00014.
4
Endothelin receptor antagonist activity of (R)-(-)-2-(benzo[1,3]dioxol-5-yl)-N-(4-isopropylphenylsulfonyl)-2-(6-methyl- 2-propylpyridin-3-yloxy)acetamide hydrochloride (PABSA) in rat aortic smooth muscle cells and isolated rat thoracic aorta.(R)-(-)-2-(苯并[1,3]二氧杂环戊烯-5-基)-N-(4-异丙基苯基磺酰基)-2-(6-甲基-2-丙基吡啶-3-基氧基)乙酰胺盐酸盐(PABSA)在大鼠主动脉平滑肌细胞和离体大鼠胸主动脉中的内皮素受体拮抗活性
Arzneimittelforschung. 2001;51(7):529-34. doi: 10.1055/s-0031-1300076.
5
Ethenesulfonamide derivatives, a novel class of orally active endothelin-A receptor antagonists.乙烯磺酰胺衍生物,一类新型的口服活性内皮素A受体拮抗剂。
Chem Pharm Bull (Tokyo). 2001 May;49(5):606-12. doi: 10.1248/cpb.49.606.
6
Ethenesulfonamide and ethanesulfonamide derivatives, a novel class of orally active endothelin-A receptor antagonists.乙烯磺酰胺和乙烷磺酰胺衍生物,一类新型的口服活性内皮素-A受体拮抗剂。
Bioorg Med Chem. 2001 Nov;9(11):2955-68. doi: 10.1016/s0968-0896(01)00187-0.
7
Pyrrolidine-3-carboxylic acids as endothelin antagonists. 3. Discovery of a potent, 2-nonaryl, highly selective ETA antagonist (A-216546).吡咯烷-3-羧酸作为内皮素拮抗剂。3. 一种强效、2-非芳基、高选择性ETA拮抗剂(A-216546)的发现。
J Med Chem. 1998 Aug 13;41(17):3261-75. doi: 10.1021/jm980217s.
8
Structure-activity relationships of cyclic pentapeptide endothelin A receptor antagonists.环五肽内皮素A受体拮抗剂的构效关系
J Med Chem. 1995 Oct 13;38(21):4309-24. doi: 10.1021/jm00021a021.
9
Structure-Activity relationships of 2-substituted 5,7-Diarylcyclopenteno[1,2-b]pyridine-6-carboxylic acids as a novel class of endothelin receptor antagonists.
Bioorg Med Chem Lett. 2002 Nov 4;12(21):3041-5. doi: 10.1016/s0960-894x(02)00663-7.
10
Potent and selective non-benzodioxole-containing endothelin-A receptor antagonists.强效且选择性的不含苯并二恶唑的内皮素-A受体拮抗剂。
J Med Chem. 1997 Jan 31;40(3):322-30. doi: 10.1021/jm960077r.